OCT 19, 2017 3:05 PM PDT

What's Toxic to Healthy Cells is Fuel for Cancer

WRITTEN BY: Xuan Pham

A breast tumor and its local environment. | Image: NCI

To fuel their growth and edge out healthy cells, breast cancer cells recycle a waste product into nutrients, researchers report.

Through various metabolic processes, cells excrete ammonia as a waste byproduct. Under normal conditions, ammonia is toxic to the body, and buildup of this compound can cause irreversible brain damage, coma, and even death.

"Classically, ammonia was thought to be metabolic waste that must be cleared due to its high toxicity," said Dr. Marcia Haigis, associate professor of cell biology at the Harvard Medical School, and the study’s senior author.

Ammonia is usually funneled via blood vessels to the liver for conversion into urea that can be carried out of the body in urine. But tumors are limited in blood vessels and lack a way to convert ammonia into urea. So it was surprising to Haigis’ team that the ammonia accumulation was not toxic to the tumors.

How do cancer cells cope with an abundance of a toxic product? They cunningly recycle it into fuel. This two-in-one solution solves the problem of ammonia buildup and also provides cancer cells with yet another growth advantage over healthy cells.

To study this phenomenon, Haigis’ team labeled the nitrogen on the amino acid glutamine, which allowed them to follow the path of subsequent nitrogen-containing ammonia byproduct. In breast cancer cells, the labeled nitrogen appeared in a different amino acid, glutamate. In fact, 20 percent of glutamate molecules contained the labeled nitrogen, suggesting cancer cells recycle the byproduct at a high efficiency.

Furthermore, ammonia seemed to stimulate the tumor’s growth. In cell cultures, cancer cells exposed to ammonia doubled at an accelerated pace – up to seven hours ahead of cells without ammonia. In mice, ammonia also stimulated the tumors to grow faster and larger. On the other hand, if ammonia was taken away, tumor growth slowed significantly.

"We found that repressing ammonia metabolism stunts tumor growth in mice," said Jessica Spinelli, the study’s lead author. "Therefore, inhibition of ammonia assimilation or ammonia production may be rational strategies for therapy design."

"We found that not only was ammonia not toxic for breast cancer cells, it could be used to feed tumors by serving as a source for the building blocks that tumors need to grow,” said Haigis.

The results highlight a side of tumor biology that was previously not well-understood. In addition, knowledge of how cancer cells use ammonia may provide new therapeutic targets to slow, and even halt, tumor’s advance.

Additional sources: Harvard Medical School

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
MAR 19, 2020
Cancer
MAR 19, 2020
Declining death rates for melanoma
Fewer people are dying from melanoma in the United States, suggests new research from the Perlmutter Cancer Center at NY ...
APR 08, 2020
Cancer
APR 08, 2020
Changing cell pH to block pancreatic cancer
New research published in Cancer Discovery suggests that manipulating the pH of pancreatic cancer cells can deter cell g ...
APR 14, 2020
Clinical & Molecular DX
APR 14, 2020
Urchin-shaped DNA Biosensor Detects Disease Earlier
For researchers at the Missouri University of Science and Technology developing a new class of nanodiagnostics, good thi ...
APR 24, 2020
Drug Discovery & Development
APR 24, 2020
Drug Targets Hard To Treat Uterine Cancer
A clinical trial was deemed successful when evaluating a therapeutic for a hard-to-treat form of uterine cancer. The dru ...
APR 29, 2020
Immunology
APR 29, 2020
New Immune Cell Discovered in Mammary Ducts
Dubbed “ductal macrophages,” newly discovered immune cells found in breast tissue offer fresh promise for fu ...
MAY 12, 2020
Drug Discovery & Development
MAY 12, 2020
Novel Drug Approved for Non-Small Cell Lung Cancer
The US Food and Drug Administration (FDA) recently approved a therapeutic for treating metastatic non-small cell lung ca ...
Loading Comments...